⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5351628 | 0.83 | — | — | |
| SCHEMBL14732304 | 0.82 | — | — | |
| SCHEMBL30775485 | 0.81 | — | — | |
| SCHEMBL8074639 | 0.81 | — | — | |
| SCHEMBL5708206 | 0.81 | — | — | |
| SCHEMBL9972598 | 0.80 | — | — | |
| SCHEMBL773718 | 0.79 | — | — | |
| SCHEMBL8060414 | 0.78 | — | — | |
| SCHEMBL12096939 | 0.78 | — | — | |
| SCHEMBL8060416 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0909749-B1 | Process for the preparation of pentafluoropentanol | BAYER AG (DE) | 2002-08-28 | — | — | EP | claimed |
| US-6002053-A | Process for preparing pentafluoropentanol | BAYER AKTIENGESELLSCHAFT (DE) | 1999-12-14 | — | — | US | claimed |
| EP-0909749-A1 | Process for the preparation of pentafluoropentanol | BAYER AG (DE) | 1999-04-21 | — | — | EP | claimed |
| JP-11180914-A | — | — | None | — | — | JP | disclosed |
| CN-114853568-A | Preparation method of 4,4,5,5, 5-penta-fluoropentanol | 辽宁迪诺医药科技有限公司 | 2022-08-05 | — | — | CN | disclosed |
| US-20070282115-A1 | Production Processes and Systems, Compositions, Surfactants, Monomer Units, Metal Complexes, Phosphate Esters, Glycols, Aqueous Film Foams, and Foam Stabilizers | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-12-06 | — | — | US | disclosed |
| US-6596885-B2 | As antiestrogenic and anti-proliferative agent | AVENTIS PHARMA S.A. (FR) | 2003-07-22 | — | — | US | disclosed |
| EP-0909749-B1 | Process for the preparation of pentafluoropentanol | BAYER AG (DE) | 2002-08-28 | — | — | EP | disclosed |
| US-20020072624-A1 | New 19-Nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, their use as medicaments and compositions | ROUSSEL UCLAF | 2002-06-13 | — | — | US | disclosed |
| US-6281204-B1 | ANTIESTROGENS | Roussel, Hoechst Marion (FR) | 2001-08-28 | — | — | US | disclosed |
| US-6002053-A | Process for preparing pentafluoropentanol | BAYER AKTIENGESELLSCHAFT (DE) | 1999-12-14 | — | — | US | disclosed |
| US-6002053-A | Process for preparing pentafluoropentanol | BAYER AKTIENGESELLSCHAFT (DE) | 1999-12-14 | — | — | US | disclosed |
| JP-H11180914-A | PRODUCTION OF PENTAFLUOROPENTANOL | BAYER AG | 1999-07-06 | — | — | JP | disclosed |
| EP-0909749-A1 | Process for the preparation of pentafluoropentanol | BAYER AG (DE) | 1999-04-21 | — | — | EP | disclosed |
| EP-0909749-A1 | Process for the preparation of pentafluoropentanol | BAYER AG (DE) | 1999-04-21 | — | — | EP | disclosed |
| EP-0623140-B1 | NOVEL 19-NOR STEROIDS HAVING A THIOCARBON-CONTAINING CHAIN IN THE 11BETA POSITION, A METHOD FOR PREPARING SAME AND INTERMEDIATES THEREFOR, MEDICINAL USES THEREOF AND COMPOSITIONS CONTAINING SAID STEROIDS | HOECHST MARION ROUSSEL INC (FR) | 1998-04-22 | — | — | EP | disclosed |
| EP-0623140-A1 | NOVEL 19-NOR STEROIDS HAVING A THIOCARBON-CONTAINING CHAIN IN THE 11BETA POSITION, A METHOD FOR PREPARING SAME AND INTERMEDIATES THEREFOR, MEDICINAL USES THEREOF AND COMPOSITIONS CONTAINING SAID STEROIDS | ROUSSEL UCLAF (FR) | 1994-11-09 | — | — | EP | disclosed |
| WO-1993013123-A1 | NOVEL 19-NOR STEROIDS HAVING A THIOCARBON-CONTAINING CHAIN IN THE 11BETA POSITION, A METHOD FOR PREPARING SAME AND INTERMEDIATES THEREFOR, MEDICINAL USES THEREOF AND COMPOSITIONS CONTAINING SAID STEROIDS | ROUSSEL-UCLAF (FR) | 1993-07-08 | — | — | WO | disclosed |